Dr. Christopher Bowlus, MD
Claim this profileGSK Investigational Site
Studies Cholangitis
Studies Liver Cirrhosis
8 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Christopher Bowlus, MD is currently running
HM15211
for Non-alcoholic Steatohepatitis (NASH)
This trial is testing a medication called HM15211 to see if it can help people with a liver disease called NASH. The study will check if the medication is safe and effective over a period of time.
Recruiting0 awards Phase 23 criteria
Volixibat
for Itching in Primary Sclerosing Cholangitis
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.
Recruiting0 awards Phase 26 criteria
More about Christopher Bowlus, MD
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Christopher Bowlus, MD has experience with
- Placebo
- Linerixibat
- Sulfasalazine
- Volixibat
- Bezafibrate
- Obeticholic Acid
Breakdown of trials Christopher Bowlus, MD has run
Cholangitis
Liver Cirrhosis
Sclerosing Cholangitis
Primary Sclerosing Cholangitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher Bowlus, MD specialize in?
Christopher Bowlus, MD focuses on Cholangitis and Liver Cirrhosis. In particular, much of their work with Cholangitis has involved treating patients, or patients who are undergoing treatment.
Is Christopher Bowlus, MD currently recruiting for clinical trials?
Yes, Christopher Bowlus, MD is currently recruiting for 5 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Christopher Bowlus, MD has studied deeply?
Yes, Christopher Bowlus, MD has studied treatments such as Placebo, Linerixibat, Sulfasalazine.
What is the best way to schedule an appointment with Christopher Bowlus, MD?
Apply for one of the trials that Christopher Bowlus, MD is conducting.
What is the office address of Christopher Bowlus, MD?
The office of Christopher Bowlus, MD is located at: GSK Investigational Site, Sacramento, California 95817 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.